Alzheimer’s disease is a progressive neurological disorder that causes memory loss, confusion, and changes in thinking and behavior. It is the most common cause of dementia and can significantly impact daily life and independence. Tekton Research is currently enrolling participants in multiple clinical trials evaluating investigational medications for Alzheimer’s disease, including studies for individuals experiencing symptoms such as agitation or psychosis.
Participating in a clinical trial may help you:
- Learn more about your condition
- Advance medical discoveries
- Access investigational therapies at no cost
- Receive compensation for time and travel expenses
- Most studies provide compensation for time and travel costs. Health insurance is generally not needed to join a clinical trial.
There is never an obligation to join — we’re here to help you make the best decision. Apply online or call (855) 248-2556 to get started.